US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 0.768
  • -0.032-3.96%
Close Mar 31 16:00 ET
  • 0.812
  • +0.044+5.78%
Pre 08:13 ET
42.36MMarket Cap-0.46P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-42.64%133.61M
-42.64%133.61M
-33.35%153.63M
-29.47%179.84M
17.22%201.92M
15.47%232.94M
15.47%232.94M
2.88%230.51M
3.53%254.99M
-35.29%172.26M
-Cash and cash equivalents
-50.68%12.47M
-50.68%12.47M
-29.96%11.13M
5.23%27.83M
35.75%24.71M
-17.36%25.29M
-17.36%25.29M
-69.44%15.9M
-47.84%26.45M
-64.75%18.2M
-Short-term investments
-41.66%121.14M
-41.66%121.14M
-33.60%142.49M
-33.48%152.02M
15.04%177.22M
21.34%207.64M
21.34%207.64M
24.76%214.61M
16.84%228.54M
-28.20%154.05M
Other current assets
-14.05%2.28M
-14.05%2.28M
-37.39%2.76M
-45.03%2.87M
14.43%3.44M
0.08%2.65M
0.08%2.65M
--4.41M
--5.22M
--3.01M
Total current assets
-42.32%135.9M
-42.32%135.9M
-33.43%156.39M
-29.78%182.71M
17.18%205.37M
15.27%235.59M
15.27%235.59M
3.54%234.92M
4.66%260.21M
-35.08%175.26M
Non current assets
Net PPE
-6.02%35.47M
-6.02%35.47M
413.75%36.38M
430.40%37.13M
455.65%37.4M
463.24%37.74M
463.24%37.74M
9.56%7.08M
15.17%7M
6.07%6.73M
-Gross PPE
-1.40%40.72M
-1.40%40.72M
413.75%36.38M
430.40%37.13M
455.65%37.4M
312.25%41.3M
312.25%41.3M
9.56%7.08M
15.17%7M
6.07%6.73M
-Accumulated depreciation
-47.45%-5.26M
-47.45%-5.26M
----
----
----
-7.44%-3.57M
-7.44%-3.57M
----
----
----
Other non current assets
-4.26%4.15M
-4.26%4.15M
-73.06%4.45M
-66.80%4.45M
-73.42%4.34M
-53.94%4.34M
-53.94%4.34M
84.09%16.51M
207.86%13.4M
275.05%16.33M
Total non current assets
-5.84%39.62M
-5.84%39.62M
73.06%40.83M
103.80%41.58M
81.03%41.74M
161.02%42.08M
161.02%42.08M
52.88%23.6M
95.58%20.4M
115.51%23.06M
Total assets
-36.79%175.52M
-36.79%175.52M
-23.71%197.22M
-20.07%224.29M
24.60%247.11M
25.93%277.67M
25.93%277.67M
6.68%258.51M
8.32%280.61M
-29.34%198.32M
Liabilities
Current liabilities
Payables
68.82%7.73M
68.82%7.73M
14.53%5.92M
10.47%6.17M
-25.05%5.31M
-32.42%4.58M
-32.42%4.58M
-49.56%5.17M
-10.97%5.59M
-4.17%7.08M
-accounts payable
68.82%7.73M
68.82%7.73M
14.53%5.92M
10.47%6.17M
-25.05%5.31M
-32.42%4.58M
-32.42%4.58M
-49.56%5.17M
-10.97%5.59M
-4.17%7.08M
Current accrued expenses
-4.41%5.42M
-4.41%5.42M
50.39%5.18M
47.13%5.33M
-20.64%5.71M
-17.73%5.67M
-17.73%5.67M
-17.56%3.45M
-1.66%3.62M
89.49%7.19M
Current debt and capital lease obligation
82.31%2.7M
82.31%2.7M
473.47%2.72M
192.00%2.74M
57.41%2.19M
-19.16%1.48M
-19.16%1.48M
-65.78%475K
-48.52%938K
-25.23%1.39M
-Current capital lease obligation
82.31%2.7M
82.31%2.7M
473.47%2.72M
192.00%2.74M
57.41%2.19M
-19.16%1.48M
-19.16%1.48M
-65.78%475K
-48.52%938K
-25.23%1.39M
Current deferred liabilities
----
----
----
--3M
----
----
----
----
----
----
Other current liabilities
-18.41%771K
-18.41%771K
-2.20%801K
--455K
-9.91%800K
80.34%945K
80.34%945K
--819K
----
--888K
Current liabilities
17.46%25.64M
17.46%25.64M
31.56%22.22M
53.62%23.34M
-10.27%17.64M
0.59%21.83M
0.59%21.83M
-21.65%16.89M
-3.93%15.19M
22.36%19.66M
Non current liabilities
Long term debt and capital lease obligation
-0.53%15.33M
-0.53%15.33M
--15.41M
--15.47M
--15.45M
--15.41M
--15.41M
----
----
----
-Long term capital lease obligation
-0.53%15.33M
-0.53%15.33M
--15.41M
--15.47M
--15.45M
--15.41M
--15.41M
----
----
----
Other non current liabilities
-7.46%3.09M
-7.46%3.09M
-6.19%3.15M
-4.34%3.22M
-2.50%3.28M
-0.65%3.34M
-0.65%3.34M
0.03%3.36M
40.04%3.36M
40.04%3.36M
Total non current liabilities
-1.77%18.42M
-1.77%18.42M
452.37%18.57M
455.79%18.68M
457.24%18.73M
457.75%18.75M
457.75%18.75M
0.03%3.36M
40.04%3.36M
20.47%3.36M
Total liabilities
8.58%44.06M
8.58%44.06M
101.39%40.79M
126.48%42.02M
57.98%36.37M
61.89%40.58M
61.89%40.58M
-18.72%20.25M
1.87%18.55M
22.08%23.02M
Shareholders'equity
Share capital
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
-common stock
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
0.00%5K
Retained earnings
-27.86%-583.56M
-27.86%-583.56M
-31.07%-554.83M
-33.07%-522.56M
-34.65%-487.82M
-36.42%-456.39M
-36.42%-456.39M
-38.38%-423.32M
-42.31%-392.71M
-45.74%-362.28M
Paid-in capital
3.13%714.98M
3.13%714.98M
7.39%711.09M
7.57%705.12M
29.89%698.79M
30.39%693.25M
30.39%693.25M
25.96%662.17M
26.27%655.47M
4.93%537.97M
Gains losses not affecting retained earnings
-84.30%35K
-84.30%35K
127.60%167K
59.21%-290K
40.95%-235K
113.18%223K
113.18%223K
74.40%-605K
69.01%-711K
82.79%-398K
Total stockholders'equity
-44.55%131.46M
-44.55%131.46M
-34.34%156.43M
-30.44%182.28M
20.22%210.73M
21.31%237.09M
21.31%237.09M
9.59%238.26M
8.81%262.06M
-33.04%175.3M
Total equity
-44.55%131.46M
-44.55%131.46M
-34.34%156.43M
-30.44%182.28M
20.22%210.73M
21.31%237.09M
21.31%237.09M
9.59%238.26M
8.81%262.06M
-33.04%175.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -42.64%133.61M-42.64%133.61M-33.35%153.63M-29.47%179.84M17.22%201.92M15.47%232.94M15.47%232.94M2.88%230.51M3.53%254.99M-35.29%172.26M
-Cash and cash equivalents -50.68%12.47M-50.68%12.47M-29.96%11.13M5.23%27.83M35.75%24.71M-17.36%25.29M-17.36%25.29M-69.44%15.9M-47.84%26.45M-64.75%18.2M
-Short-term investments -41.66%121.14M-41.66%121.14M-33.60%142.49M-33.48%152.02M15.04%177.22M21.34%207.64M21.34%207.64M24.76%214.61M16.84%228.54M-28.20%154.05M
Other current assets -14.05%2.28M-14.05%2.28M-37.39%2.76M-45.03%2.87M14.43%3.44M0.08%2.65M0.08%2.65M--4.41M--5.22M--3.01M
Total current assets -42.32%135.9M-42.32%135.9M-33.43%156.39M-29.78%182.71M17.18%205.37M15.27%235.59M15.27%235.59M3.54%234.92M4.66%260.21M-35.08%175.26M
Non current assets
Net PPE -6.02%35.47M-6.02%35.47M413.75%36.38M430.40%37.13M455.65%37.4M463.24%37.74M463.24%37.74M9.56%7.08M15.17%7M6.07%6.73M
-Gross PPE -1.40%40.72M-1.40%40.72M413.75%36.38M430.40%37.13M455.65%37.4M312.25%41.3M312.25%41.3M9.56%7.08M15.17%7M6.07%6.73M
-Accumulated depreciation -47.45%-5.26M-47.45%-5.26M-------------7.44%-3.57M-7.44%-3.57M------------
Other non current assets -4.26%4.15M-4.26%4.15M-73.06%4.45M-66.80%4.45M-73.42%4.34M-53.94%4.34M-53.94%4.34M84.09%16.51M207.86%13.4M275.05%16.33M
Total non current assets -5.84%39.62M-5.84%39.62M73.06%40.83M103.80%41.58M81.03%41.74M161.02%42.08M161.02%42.08M52.88%23.6M95.58%20.4M115.51%23.06M
Total assets -36.79%175.52M-36.79%175.52M-23.71%197.22M-20.07%224.29M24.60%247.11M25.93%277.67M25.93%277.67M6.68%258.51M8.32%280.61M-29.34%198.32M
Liabilities
Current liabilities
Payables 68.82%7.73M68.82%7.73M14.53%5.92M10.47%6.17M-25.05%5.31M-32.42%4.58M-32.42%4.58M-49.56%5.17M-10.97%5.59M-4.17%7.08M
-accounts payable 68.82%7.73M68.82%7.73M14.53%5.92M10.47%6.17M-25.05%5.31M-32.42%4.58M-32.42%4.58M-49.56%5.17M-10.97%5.59M-4.17%7.08M
Current accrued expenses -4.41%5.42M-4.41%5.42M50.39%5.18M47.13%5.33M-20.64%5.71M-17.73%5.67M-17.73%5.67M-17.56%3.45M-1.66%3.62M89.49%7.19M
Current debt and capital lease obligation 82.31%2.7M82.31%2.7M473.47%2.72M192.00%2.74M57.41%2.19M-19.16%1.48M-19.16%1.48M-65.78%475K-48.52%938K-25.23%1.39M
-Current capital lease obligation 82.31%2.7M82.31%2.7M473.47%2.72M192.00%2.74M57.41%2.19M-19.16%1.48M-19.16%1.48M-65.78%475K-48.52%938K-25.23%1.39M
Current deferred liabilities --------------3M------------------------
Other current liabilities -18.41%771K-18.41%771K-2.20%801K--455K-9.91%800K80.34%945K80.34%945K--819K------888K
Current liabilities 17.46%25.64M17.46%25.64M31.56%22.22M53.62%23.34M-10.27%17.64M0.59%21.83M0.59%21.83M-21.65%16.89M-3.93%15.19M22.36%19.66M
Non current liabilities
Long term debt and capital lease obligation -0.53%15.33M-0.53%15.33M--15.41M--15.47M--15.45M--15.41M--15.41M------------
-Long term capital lease obligation -0.53%15.33M-0.53%15.33M--15.41M--15.47M--15.45M--15.41M--15.41M------------
Other non current liabilities -7.46%3.09M-7.46%3.09M-6.19%3.15M-4.34%3.22M-2.50%3.28M-0.65%3.34M-0.65%3.34M0.03%3.36M40.04%3.36M40.04%3.36M
Total non current liabilities -1.77%18.42M-1.77%18.42M452.37%18.57M455.79%18.68M457.24%18.73M457.75%18.75M457.75%18.75M0.03%3.36M40.04%3.36M20.47%3.36M
Total liabilities 8.58%44.06M8.58%44.06M101.39%40.79M126.48%42.02M57.98%36.37M61.89%40.58M61.89%40.58M-18.72%20.25M1.87%18.55M22.08%23.02M
Shareholders'equity
Share capital 0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K
-common stock 0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K0.00%5K
Retained earnings -27.86%-583.56M-27.86%-583.56M-31.07%-554.83M-33.07%-522.56M-34.65%-487.82M-36.42%-456.39M-36.42%-456.39M-38.38%-423.32M-42.31%-392.71M-45.74%-362.28M
Paid-in capital 3.13%714.98M3.13%714.98M7.39%711.09M7.57%705.12M29.89%698.79M30.39%693.25M30.39%693.25M25.96%662.17M26.27%655.47M4.93%537.97M
Gains losses not affecting retained earnings -84.30%35K-84.30%35K127.60%167K59.21%-290K40.95%-235K113.18%223K113.18%223K74.40%-605K69.01%-711K82.79%-398K
Total stockholders'equity -44.55%131.46M-44.55%131.46M-34.34%156.43M-30.44%182.28M20.22%210.73M21.31%237.09M21.31%237.09M9.59%238.26M8.81%262.06M-33.04%175.3M
Total equity -44.55%131.46M-44.55%131.46M-34.34%156.43M-30.44%182.28M20.22%210.73M21.31%237.09M21.31%237.09M9.59%238.26M8.81%262.06M-33.04%175.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 46.620
Sample Name
Sample Code
 97.600
Sample Name
Sample Code
 67.730
4
DexCom
DXCM
68.290
5
Collegium Pharmaceutical
COLL
29.850
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 10.440
Sample Name
Sample Code
 222.130
Sample Name
Sample Code
 127.130
4
Meritage Homes
MTH
70.880
5
Lennar Corp
LEN
114.780
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 222.130
Sample Name
Sample Code
 61.710
Sample Name
Sample Code
 98.700
4
Qualcomm
QCOM
153.610
5
Taiwan Semiconductor
TSM
166.000
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 15.0100
Sample Name
Sample Code
 2.730
Sample Name
Sample Code
 6.090
4
Digihost Technology
DGHI
1.320
5
Hut 8
HUT
11.620
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -